These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 28783870)
1. CXCR4 antagonist delivery on decellularized skin scaffold facilitates impaired wound healing in diabetic mice by increasing expression of SDF-1 and enhancing migration of CXCR4-positive cells. Liu H; Liu H; Deng X; Chen M; Han X; Yan W; Wang N Wound Repair Regen; 2017 Aug; 25(4):652-664. PubMed ID: 28783870 [TBL] [Abstract][Full Text] [Related]
5. Mobilization of endothelial progenitor cells promotes angiogenesis after full thickness excision by AMD3100 combined with G-CSF in diabetic mice by SDF-1/CXCR4 axis. Lin X; Wang H; Li X Diab Vasc Dis Res; 2021; 18(2):14791641211002473. PubMed ID: 33779350 [TBL] [Abstract][Full Text] [Related]
6. Acellular dermal matrix scaffolds coated with connective tissue growth factor accelerate diabetic wound healing by increasing fibronectin through PKC signalling pathway. Yan W; Liu H; Deng X; Jin Y; Wang N; Chu J J Tissue Eng Regen Med; 2018 Mar; 12(3):e1461-e1473. PubMed ID: 28872257 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of CXC chemokine receptor 4 antagonist AMD3100 on bleomycin induced murine pulmonary fibrosis. Song JS; Kang CM; Kang HH; Yoon HK; Kim YK; Kim KH; Moon HS; Park SH Exp Mol Med; 2010 Jun; 42(6):465-72. PubMed ID: 20498529 [TBL] [Abstract][Full Text] [Related]
8. Supercritical Carbon Dioxide-decellularized Porcine Acellular Dermal Matrix combined with Autologous Adipose-derived Stem Cells: Its Role in Accelerated Diabetic Wound Healing. Chou PR; Lin YN; Wu SH; Lin SD; Srinivasan P; Hsieh DJ; Huang SH Int J Med Sci; 2020; 17(3):354-367. PubMed ID: 32132871 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of the SDF-1alpha-CXCR4 axis by the CXCR4 antagonist AMD3100 suppresses the migration of cultured cells from ATL patients and murine lymphoblastoid cells from HTLV-I Tax transgenic mice. Kawaguchi A; Orba Y; Kimura T; Iha H; Ogata M; Tsuji T; Ainai A; Sata T; Okamoto T; Hall WW; Sawa H; Hasegawa H Blood; 2009 Oct; 114(14):2961-8. PubMed ID: 19657116 [TBL] [Abstract][Full Text] [Related]
11. Functional potentials of human hematopoietic progenitor cells are maintained by mesenchymal stromal cells and not impaired by plerixafor. Ludwig A; Saffrich R; Eckstein V; Bruckner T; Wagner W; Ho AD; Wuchter P Cytotherapy; 2014 Jan; 16(1):111-21. PubMed ID: 24119647 [TBL] [Abstract][Full Text] [Related]
12. Low-Dose Radiation Promotes the Proliferation and Migration of AGE-Treated Endothelial Progenitor Cells Derived from Bone Marrow via Activating SDF-1/CXCR4/ERK Signaling Pathway. Wang P; Zhang H; Li Z; Liu X; Jin Y; Lei M; Jiao Z; Bi Y; Guo W Radiat Res; 2019 Jun; 191(6):518-526. PubMed ID: 30925138 [TBL] [Abstract][Full Text] [Related]
13. Hair follicle stem cells promote cutaneous wound healing through the SDF-1α/CXCR4 axis: an animal model. Yari A; Heidari F; Veijouye SJ; Nobakht M J Wound Care; 2020 Sep; 29(9):526-536. PubMed ID: 32924817 [TBL] [Abstract][Full Text] [Related]
14. [Effects of allogeneic mouse adipose-derived mesenchymal stem cell-microporous sheep acellular dermal matrix on healing of wound with full-thickness skin defect in mouse and the related mechanism]. Cao SJ; Wang LF; Ba T; Fu X; Li F; Hao CG Zhonghua Shao Shang Za Zhi; 2018 Dec; 34(12):901-906. PubMed ID: 30585055 [No Abstract] [Full Text] [Related]
15. AMD3100 and CD26 modulate mobilization, engraftment, and survival of hematopoietic stem and progenitor cells mediated by the SDF-1/CXCL12-CXCR4 axis. Broxmeyer HE; Hangoc G; Cooper S; Campbell T; Ito S; Mantel C Ann N Y Acad Sci; 2007 Jun; 1106():1-19. PubMed ID: 17360804 [TBL] [Abstract][Full Text] [Related]
16. AMD3100 inhibits epithelial-mesenchymal transition, cell invasion, and metastasis in the liver and the lung through blocking the SDF-1α/CXCR4 signaling pathway in prostate cancer. Zhu WB; Zhao ZF; Zhou X J Cell Physiol; 2019 Jul; 234(7):11746-11759. PubMed ID: 30537000 [TBL] [Abstract][Full Text] [Related]
18. Short-term intermittent administration of CXCR4 antagonist AMD3100 facilitates myocardial repair in experimental myocardial infarction. Luo Y; Zhao X; Zhou X; Ji W; Zhang L; Luo T; Liu H; Huang T; Jiang T; Li Y Acta Biochim Biophys Sin (Shanghai); 2013 Jul; 45(7):561-9. PubMed ID: 23676772 [TBL] [Abstract][Full Text] [Related]
19. AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell-based microenvironment: pre-clinical evidence for its association with chronic lymphocytic leukemia treatments. Stamatopoulos B; Meuleman N; De Bruyn C; Pieters K; Mineur P; Le Roy C; Saint-Georges S; Varin-Blank N; Cymbalista F; Bron D; Lagneaux L Haematologica; 2012 Apr; 97(4):608-15. PubMed ID: 22058221 [TBL] [Abstract][Full Text] [Related]
20. Effect of SDF-1/Cxcr4 Signaling Antagonist AMD3100 on Bone Mineralization in Distraction Osteogenesis. Xu J; Chen Y; Liu Y; Zhang J; Kang Q; Ho K; Chai Y; Li G Calcif Tissue Int; 2017 Jun; 100(6):641-652. PubMed ID: 28303319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]